Abstract
Cancer cells exhibit an altered metabolic phenotype, known as the Warburg effect, which is characterized by high rates of glucose uptake and glycolysis, even under aerobic conditions. The Warburg effect appears to be an intrinsic component of most cancers and there is evidence linking cancer progression to mutations, translocations, and alternative splicing of genes that directly code for or have downstream effects on key metabolic enzymes. Many of the same signaling pathways are routinely dysregulated in cancer and a number of important oncogenic signaling pathways play important regulatory roles in central carbon metabolism. Unraveling the complex regulatory relationship between cancer metabolism and signaling requires the application of systems biology approaches. Here we discuss computational approaches for modeling protein signal transduction and metabolism as well as how the regulatory relationship between these two important cellular processes can be combined into hybrid models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The idea of a Laplace Demon came from a thought experiment proposed by Pierre-Simon Laplace of a perfect entity who would know the precise location of each atom and of all forces in nature at any given moment. This entity (or demon, as it later came to be called) would have incredible predictive power because it could infer the past and determine the future from any set of initial conditions.
References
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18(1):54–61
Nakajo M, Jinnouchi S, Inoue H, Otsuka M, Matsumoto T, Kukita T, Tanabe H, Tateno R, Nakajo M (2007) FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment. Clin Nucl Med 32(10):775–778
Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134(5): 703–707
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033
Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49(Suppl 2):24S–42S
Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, Xie J, Gu TL, Polakiewicz RD, Roesel JL, Boggon TJ, Khuri FR, Gilliland DG, Cantley LC, Kaufman J, Chen J (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2(97):ra73
Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452(7184):181–186
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799
Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489–501
Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, Thompson CB (2005) The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24(26):4165–4173
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64(11):3892–3899
Thompson CB (2009) Metabolic enzymes as oncogenes or tumor suppressors. New Engl J Med 360(8):813–815
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184):230–233
Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313(3):459–465
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK (2006) Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8(11):1195–1203
Turner TE, Schnell S, Burrage K (2004) Stochastic approaches for modelling in vivo reactions. Comput Biol Chem 28(3):165–178
Cornish-Bowden A (2004) Fundamentals of enzyme kinetics, 3rd edn. Portland, London
Goldbeter A, Koshland DE Jr (1981) An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci USA 78(11):6840–6844
Kholodenko BN (2006) Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7(3):165–176
Flach EH, Schnell S (2006) Use and abuse of the quasi-steady-state approximation. Syst Biol 153(4):187–191
Segel LA (1984) Modeling dynamic phenomena in molecular and cellular biology. Cambridge University Press, Cambridge
Gombert AK, Nielsen J (2000) Mathematical modelling of metabolism. Curr Opin Biotechnol 11(2):180–186
Heinrich R, Schuster S (1996) The regulation of cellular systems. New York
Albert I, Thakar J, Li S, Zhang R, Albert R (2008) Boolean network simulations for life scientists. Source Code Biol Med 3:16
Thomas R, D’Ari R (1990) Biological Feeback. CRC, Boca Raton
Goldbeter A, Lefever R (1972) Dissipative structures for an allosteric model. Application to glycolytic oscillations. Biophys J 12(10):1302–1315
Sel’kov EE (1968) Self-oscillations in glycolysis. 1. A simple kinetic model. Eur J Biochem 4(1):79–86
Heinrich R, Rapoport SM, Rapoport TA (1977) Metabolic regulation and mathematical models. Prog Biophys Mol Biol 32(1):1–82
Heinrich R, Schuster S (1996) The regulation of cellular systems. Chapman & Hall, New York
Fersht A (1999) Structure and mechanism in protein science: A guide to enzyme catalysis and protein folding. WH Freeman, New York
Schnell S, Maini PK (2003) A century of enzyme kinetics: reliability of the KMand vmaxestimates. Comm Theor Biol 8(2–3):169–187
Cook PF, Cleland WW (2007) Enzyme kinetics and mechanism. Garland Science, London
Savageau MA (1969) Biochemical systems analysis. I. Some mathematical properties of the rate law for the component enzymatic reactions. J Theor Biol 25(3):365–369
Savageau MA (1969) Biochemical systems analysis. II. The steady-state solutions for an n-pool system using a power-law approximation. J Theor Biol 25(3):370–379
Savageau MA (1970) Biochemical systems analysis. III. Dynamic solutions using a power-law approximation. J Theor Biol 26(2):215–226
Kacser H, Burns JA (1973) The control of flux. Symp Soc Exp Biol 27:65–104
Heinrich R, Rapoport TA (1974) A linear steady state treatment of enzymatic chains: general properties, control and effector strength. Eur J Biochem 42(1):89–95
Heinrich R, Rapoport TA (1974) A linear steady state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector. Eur J Biochem 42(1):97–105
Crabtree B, Newsholme EA (1978) Sensitivity of a near-equilibrium reaction in a metabolic pathway to changes in substrate concentration. Eur J Biochem 89(1):19–22
Crabtree B, Newsholme EA (1985) A quantitative approach to metabolic control. Curr Top Cell Reg 25:21–76
Crabtree B, Newsholme EA (1987) The derivation and interpretation of control coefficients. Biochem J 247(1):113–120
Varma A, Morbidelli M, Wu H (1999) Parametric sensitivity in chemical systems. Cambridge University Press, New York
Fell D (1997) Understanding the control of metabolism. Frontiers in metabolism. Portland, London
Voit EO (2000) Computational analysis of biochemical systems: A practical guide for biochemists and molecular biologists. Cambridge University Press, New York
Cornish-Bowden A, Cardenas ML (2005) Systems biology may work when we learn to understand the parts in terms of the whole. Biochem Soc Trans 33(3):516–519
Piedrafita G, Montero F, Morán F, Cárdenas ML, Cornish-Bowden A (2010) A simple self-maintaining metabolic system: Robustness, autocatalysis, bistability. PLoS Comput Biol 6(8):e1000872
Rosen R (1991) Life itself: a comprenhensive inquiry into the nature of origin and fabrication of life. Columbia University Press, New York
Cornish-Bowden A, Cárdenas ML, Letelier JC, Soto-Andrade J (2007) Beyond reductionism: metabolic circularity as a guiding vision for a real biology of systems. Proteomics 7(6):839–845
Letelier JC, Soto-Andrade J, GuÃñez Abarzúa F, Cornish-Bowden A, Luz Cárdenas M (2006) Organizational invariance and metabolic closure: analysis in terms of (M, R) systems. J Theor Biol 238(4):949–961
Huang CY, Ferrell JE Jr (1996) Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 93(19):10078–10083
Ventura AC, Jiang P, Van Wassenhove L, Del Vecchio D, Merajver SD, Ninfa AJ (2010) Signaling properties of a covalent modification cycle are altered by a downstream target. Proc Natl Acad Sci USA 107(22):10032–10037
Ventura AC, Sepulchre JA, Merajver SD (2008) A hidden feedback in signaling cascades is revealed. PLoS Comput Biol 4(3):e1000041
Aldridge BB, Saez-Rodriguez J, Muhlich JL, Sorger PK, Lauffenburger DA (2009) Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling. PLoS Comput Biol 5(4):e1000340
Albert R, Othmer HG (2003) The topology of the regulatory interactions predicts the expression pattern of the segment polarity genes in Drosophila melanogaster. J Theor Biol 223(1):1–18
Li S, Assmann SM, Albert R (2006) Predicting essential components of signal transduction networks: a dynamic model of guard cell abscisic acid signaling. PLoS Biol 4(10):e312
Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP Jr (2008) Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci USA 105(42):16308–16313
Anderson AR, Quaranta V (2008) Integrative mathematical oncology. Nat Rev Cancer 8(3):227–234
Alarcon T, Byrne HM, Maini PK (2004) A multiple scale model for tumor growth. Multiscale Model Sim 3(2):440–467
Ribba B, Colin T, Schnell S (2006) A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theor Biol Med Model 3:7
Ribba B, Saut O, Colin T, Bresch D, Grenier E, Boissel JP (2006) A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J Theor Biol 243(4):532–541
Frieboes HB, Chaplain MA, Thompson AM, Bearer EL, Lowengrub JS, Cristini V (2011) Physical oncology: a bench-to-bedside quantitative and predictive approach. Cancer Res 71(2):298–302
Singhania R, Sramkoski RM, Jacobberger JW, Tyson JJ (2011) A hybrid model of mammalian cell cycle regulation. PLoS Comput Biol 7(2):e1001077
Eden E, Geva-Zatorsky N, Issaeva I, Cohen A, Dekel E, Danon T, Cohen L, Mayo A, Alon U (2011) Proteome half-life dynamics in living human cells. Science 331(6018):764–768
Berg JM, Tymoczko JL, Stryer L (2002) Biochemistry. 5th edn. WH Freeman, New York
Acknowledgements
This work was partially supported by the University of Michigan Center for Computational Medicine & Bioinformatics Pilot Grant 2010 and the National Science Foundation under Grant No. DMS-1135663. MLW acknowledges support from the Rackham Merit Fellowship, NIH T32 CA140044, and the Breast Cancer Research Foundation. SDM acknowledges support from the Burroughs Wellcome Fund, Breast Cancer Research Foundation, the Avon Foundation and NIH CA77612. SS acknowledges support from NIDDK R25 DK088752.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Wynn, M.L., Merajver, S.D., Schnell, S. (2012). Unraveling the Complex Regulatory Relationships Between Metabolism and Signal Transduction in Cancer. In: Goryanin, I.I., Goryachev, A.B. (eds) Advances in Systems Biology. Advances in Experimental Medicine and Biology, vol 736. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7210-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7210-1_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7209-5
Online ISBN: 978-1-4419-7210-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)